NWMP
GSK icon

Noble Wealth Management PBC’s GSK GSK Stock Holding History

Noble Wealth Management PBC’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$771 Hold
16
– – ﹤0.01% 720
2026
Q2 		$839 Buy
+16
New +$846 ﹤0.01% 734
2025
Q1 		$3.25K Hold
84
– – ﹤0.01% 463
2024
Q4 		$2.84K Buy
+84
New +$3.02K ﹤0.01% 429

Other funds holding GSK

KFP
Keystone Financial Planning Cleveland, Ohio $404M AUM 16.77% 1-Year Est. Return
BE
Bonness Enterprises Washington, District of Columbia $307M AUM 22.88% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
PC
Parrish Capital Kennesaw, Georgia $103M AUM 35.11% 1-Year Est. Return
IRC
Investors Research Corp Atlanta, Georgia $569M AUM 15.41% 1-Year Est. Return
BCM
Boltwood Capital Management Walnut Creek, California $443M AUM 17.72% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
CPBTD
Central Pacific Bank - Trust Division Honolulu, Hawaii $952M AUM 25.15% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
RT
Rockland Trust Hanover, Massachusetts $2.61B AUM 14.26% 1-Year Est. Return

Noble Wealth Management PBC's GSK Position: Q3 2026 in Review

Noble Wealth Management PBC held its GSK (GSK) position steady in Q3 2026 at 16 shares worth $771. The position accounts for ﹤0.01% of the portfolio, ranked #720.

Noble Wealth Management PBC first reported a position in GSK in Q4 2024 and has held it in 4 quarters since. The position peaked at $3.25K in Q1 2025. 31 funds tracked by Wall St. Rank hold GSK as of Q3 2026.

  • Noble Wealth Management PBC held 16 shares of GSK worth $771 as of Q3 2026.
  • Noble Wealth Management PBC left its GSK share count unchanged in Q3 2026.
  • GSK made up ﹤0.01% of Noble Wealth Management PBC's portfolio in Q3 2026, its #720 holding.
  • Noble Wealth Management PBC first reported a position in GSK in Q4 2024 and has held it in 4 quarters since.
  • Noble Wealth Management PBC's GSK position peaked at $3.25K in Q1 2025.
  • 31 funds tracked by Wall St. Rank held GSK as of Q3 2026.

Based on Noble Wealth Management PBC's 13F filing for Q3 2026, filed 1 Oct 2026.